The average life expectancy of people diagnosed with dementia ranges from nine years at age 60 to 4.5 years at age 85 for ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
A milestone review examining 1.4 million patients worldwide found that those who do not see the same doctor regularly are ...